Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -7.85
Insider Own: 34.02%
Shs Outstand: 20.98M
Perf Week: 14.94%
Market Cap: 74.28M
Forward P/E: -
EPS next Y: -1.77
Insider Trans: 8.30%
Shs Float: 13.85M
Perf Month: 44.49%
Enterprise Value: 122.10M
PEG: -
EPS next Q: -1.68
Inst Own: 46.33%
Short Float: 7.21%
Perf Quarter: 25.09%
Income: -164.28M
P/S: 74.28
EPS this Y: 19.79%
Inst Trans: -14.48%
Short Ratio: 5.70
Perf Half Y: -22.71%
Sales: 1.00M
P/B: -
EPS next Y Percentage: 66.74%
ROA: -93.88%
Short Interest: 1.00M
Perf YTD: -24.20%
Book/sh: -0.96
P/C: 1.67
EPS next 5Y: 36.36%
ROE: -222.28%
52W High: 8.56 -58.64%
Perf Year: -47.71%
Cash/sh: 2.12
P/FCF: -
EPS past 3/5Y: 23.61% 8.03%
ROIC: -254.14%
52W Low: 1.78 98.88%
Perf 3Y: -69.48%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -48.91% 31.95%
Gross Margin: -191.80%
Volatility W: 7.39%
Volatility M: 7.91%
Perf 5Y: -97.10%
Dividend TTM: -
EV/Sales: 122.10
EPS Y/Y TTM: 1.80%
Oper. Margin: -17441.50%
ATR (14): 0.22
Perf 10Y: -96.72%
Dividend Ex-Date: -
Quick Ratio: 1.54
Sales Y/Y TTM: -72.22%
Profit Margin: -16427.50%
RSI (14): 71.73
Recom: 1.40
Dividend Gr. 3/5Y: - -
Current Ratio: 1.54
EPS Q/Q: -164.26%
SMA20: 19.38%
Beta: 0.88
Target Price: 19.50
Payout: -
Debt/Eq: -
Sales Q/Q: -
SMA50: 31.39%
Rel Volume: 0.58
Prev Close: 3.52
Employees: 155
LT Debt/Eq: -
Earnings: Aug 12 BMO
SMA200: -4.78%
Avg Volume: 175.14K
Price: 3.54
IPO: Jul 31, 2014
Option/Short: Yes / Yes
EPS/Sales Surpr.: -4.15% -
Trades:
Volume: 103,351
Change: 0.57%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z